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Background
Hematopoietic stem cells located in the bone marrow interact with a specific microenviron-
ment referred to as the stem cell niche. Data derived from ex vivo co-culture systems using mes-
enchymal stromal cells as a feeder cell layer suggest that cell-to-cell contact has a significant
impact on the expansion, migratory potential and ‘stemness’ of hematopoietic stem cells. Here
we investigated in detail the spatial relationship between hematopoietic stem cells and mes-
enchymal stromal cells during ex vivo expansion.
Design and Methods
In the co-culture system, we defined three distinct localizations of hematopoietic stem cells rel-
ative to the mesenchymal stromal cell layer: (i) those in supernatant (non-adherent cells); (ii)
those adhering to the surface of mesenchymal stromal cells (phase-bright cells) and (iii) those
beneath the mesenchymal stromal cells (phase-dim cells). Cell cycle, proliferation, cell division
and immunophenotype of these three cell fractions were evaluated from day 1 to 7.
Results
Phase-bright cells contained the highest proportion of cycling progenitors during co-culture. In
contrast, phase-dim cells divided much more slowly and retained a more immature phenotype
compared to the other cell fractions. The phase-dim compartment was soon enriched for
CD34+/CD38– cells. Migration beneath the mesenchymal stromal cell layer could be hampered
by inhibiting integrin β1 or CXCR4.
Conclusions
Our data suggest that the mesenchymal stromal cell surface is the predominant site of prolifer-
ation of hematopoietic stem cells, whereas the compartment beneath the mesenchymal stro-
mal cell layer seems to mimic the stem cell niche for more immature cells. The SDF-1/CXCR4
interaction and integrin-mediated cell adhesion play important roles in the distribution of
hematopoietic stem cells in the co-culture system.
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Introduction
Hematopoietic stem cells (HSC) are defined by their
ability to give rise to all types of blood cells.1-3 During the
last three decades hematopoietic stem cell transplanta-
tion has become a well established treatment for hema-
tologic malignancies and non-malignant disorders. Lately
HSC have been attracting ever increasing attention for
their potential use in regenerative medicine and tissue
engineering.4 HSC can be harvested from healthy donors
by bone marrow aspiration, by peripheral stem cell
mobilization or from cord blood. To improve the clinical
outcome of autologous and allogeneic HSC transplanta-
tion many groups are focusing on ex vivo expansion of
HSC particularly for those cases in which the graft is of
limited size. Unfortunately, the expansion of HSC in vitro
is difficult to achieve because as the cells proliferate they
tend to differentiate.5 This is presumably caused by a
lack of appropriate cues that are provided in vivo by the
microenvironment. In nature HSC are located mainly in
the bone marrow where they interact within a specific
microenvironment called the stem cell niche, which reg-
ulates their fate in terms of quiescence, self-renewal and
differentiation.6-8 Recent data suggest that quiescent HSC
are primarily located in the trabecular endosteum (i.e. the
osteoblastic niche) whereas dividing ones reside in sinu-
soidal perivascular areas (i.e. the vascular niche) of the
bone marrow.9,10 HSC can be released from the vascular
niche into the circulation in response to stress or injury.11
An orchestra of signals mediated by soluble factors
and/or cell-to-cell contact regulates the balance and
homeostasis of self-renewal, proliferation and differenti-
ation in vivo.12 Though important regulatory components
of the stem cell niche in vivo have been identified, this
has not been translated into improved ex vivo expansion
protocols for clinical applications. The best defined cul-
ture medium for HSC expansion is supplemented with
cytokines such as fetal liver tyrosine kinase-3 ligand
(FLT3-L), stem cell factor (SCF), interleukin-3 (IL-3) and
thrombopoietin (TPO).13,14 Interestingly, mesenchymal
stromal cells (MSC), which are characterized by multi-
differentiation potential,15,16 are important components of
the bone marrow HSC niche.17 In recent years, MSC
have been shown to support HSC maintenance and
engraftment.18,19 In addition, MSC have been described to
have immuno-modulatory activity.20
According to several recent studies, including those
from our laboratory, MSC facilitate HSC maintenance in
an in vitro co-culture system through the secretion of sol-
uble factors and cell-cell contact.21-24 In addition evidence
is emerging that a three-dimensional architecture is
important to mimic physiological conditions ex vivo.11,25
This prompted us to investigate how HSC interact with
MSC in different spatial compartments over time in vitro.
Usually HSC in co-culture are considered as a single pop-
ulation, and their localization relative to the MSC layer
has not been investigated intensively. In this study, MSC
served as a physical boundary of distinct compartments,
and the properties and features of HSC in different sites
were evaluated at various times in order to gain insight
into the construction and function of a three-dimension-
al HSC–MSC co-culture microenvironment in vitro.
Design and Methods
Purification of CD34+ hematopoietic stem cells from
mobilized peripheral blood
Mobilized peripheral blood was collected from healthy donors
after treatment with 7.5 μg/kg granulocyte colony-stimulating factor
for 5 days. CD34+ HSC were purified from leukapheresis samples
using CD34 antibody-conjugated magnetic beads according to the
manufacturer’s instructions (Miltenyi Biotec, Germany). The purity
of CD34+ cells was evaluated by flow cytometry analysis using phy-
coerythrin (PE)-conjugated CD34 antibody (Miltenyi Biotec,
Germany).
Isolation of mesenchymal stromal cells
MSC were isolated from bone marrow aspirates from healthy
donors, after informed consent and approval by the local ethics com-
mittee, and cultured as described elsewhere.26 The phenotype of all
MSC batches was tested by fluorescence-activated cell sorting
(FACS): CDw90, CD105, CD166, and CD73 had to be present,
whereas CD34 and CD45 had to be absent. MSC batches used in the
co-cultures had been tested for their potential to differentiate along
the osteogenic and adipogenic lineages using standard commercial
differentiation media. MSC of passage two were then seeded in 12-
or 24-well plates at a density of 1×104 cells/cm2 with MSC medium.
The medium was changed every 3 days until the MSC feeder layer
reached confluence. 
Co-culture of hematopoietic stem cells with 
the mesenchymal stromal cell layer 
CD34+ HSC were suspended in CellGro® SCGM medium
(CellGenix, Freiburg, Germany) containing 10% fetal calf serum
(Biochrom, Cambridge, UK), 150 ng/mL FLT3-L, 150 ng/mL SCF
(both from Biosource, Camarillo, CA, USA) and 50 ng/mL IL-3
(Miltenyi Biotec, Germany). HSC suspensions were plated at a den-
sity of 1×104 cells/cm2 on a confluent MSC layer at 37°C in 5% CO2.
In some experiments HSC were cultured without MSC in a cytokine-
driven assay. After 4 days the cell suspension containing around 50%
CD34+CD38– cells was seeded on an MSC layer for 5 h for further
analysis.
Scanning electron microscopy
Samples for the scanning electron microscopy analysis were pre-
pared as previously described.27 Briefly, the co-cultured cells growing
on fibronectin-coated coverslips were fixed in 2% glutaraldehyde for
1 h at room temperature and then overnight at 4°C. After being sub-
jected to dehydration in an acetone gradient (30-100%), cells were
critical point-dried in a CO2 system (Critical Point Dryer CPD 030,
BAL-TEC GmbH, Germany). Samples were then sputter-coated with
gold (Sputter Coating Device SCD 050, BAL-TEC GmbH) and exam-
ined at 10 kV accelerating voltage in an environmental scanning elec-
tron microscope (PHILIPS XL 30 ESEM FEG, Philips, The
Netherlands).
Time-lapse video microscopy
Freshly isolated CD34+ HSC were cultured on MSC growing on 24
x 60 mm fibronectin-coated coverslips attached to a silicone reusable
chamber. During the time-lapse recording, cells were kept in a cham-
ber at 37°C in a 5% CO2 atmosphere. Serial phase contrast images
were captured with an inverted microscope (Zeiss Axiovert 200M;
20X objective) at 30 s intervals. The images were built into a movie
using Metamorph software.
Immunofluorescence microscopy
After co-culture the supernatant was discarded and the MSC layer
was washed twice gently. Next the remaining cells, including phase-
HSC in co-culture 
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bright and phase-dim cells along with the MSC layer, were fixed
using 3.8% formaldehyde in phosphate-buffered saline (PBS) for 15
min and permeabilized using 0.1% Triton X-100 in PBS for 3 to 4
min. After blocking, cells were incubated with CD45-PE (1:10;
Miltenyi Biotec, Germany) for 1 h and then incubated with anti-
mouse-TRITC (1:400; Sigma, USA) and phaloidin-ALEXA488
(1:500; Invitrogen, UK) for 1 h at room temperature. The nuclei were
then labeled with 4',6-diamidino-2-phenylindole (DAPI; Sigma,
USA). Finally, confocal microscopy (Zeiss LSM 510, Germany) was
used to determine fluorescence.
Cell collection from three distinct localizations
HSC/MSC co-cultures were prepared as described above. On each
day during the first week HSC from three distinct localizations in the
co-culture were collected separately. Briefly, the supernatant of the co-
culture was aspirated and the cells in the supernatant (non-adherent
cells) were collected. The MSC layer was gently washed twice with
PBS to remove the remaining non-adherent cells. After washing, the
cells remaining on the MSC layer (i.e. phase-bright cells) were collect-
ed by further intensive washing steps with PBS. When no phase-
bright cells could be observed under phase-contrast microscopy, the
MSC layer with the cells underneath the layer (phase-dim cells) was
trypsinized and collected as well. To rule out any side effect of the
trypsin treatment, non-adherent cells and phase-bright cells were also
incubated with this enzyme for 5 min. Finally, the three cell fractions
were counted using trypan blue (vitality more than 95%) and meas-
ured as described below. 
Cell cycle analysis using propidium iodide
After collection, the cells were fixed overnight at 4°C with cold
70% ethanol. They were then washed and incubated in PBS with 50
μg/mL propidium iodide and 1 mg/mL RNase A (both from Sigma,
USA) for 30 min at room temperature. After washing, the cells were
measured by flow cytometry (FACScalibur; BD, Germany). Finally,
the FACS data were analyzed using Modifit software (Becton
Dickinson), and the proportions of cells in the G0/G1 phase, S phase
and G2/M phase of the cell cycle were calculated automatically.
Polymerase chain reaction analysis
After 5 days of co-culture, cells from the three compartments
were labeled with antihuman CD45-fluorescein isothiocyanate and
CD166-PE. The cells were then sorted and MSC were discarded
based on their forward-scatter and side-scatter properties, and
CD45+CD166– staining using BD FACSAria and B&D FACSDiva
software. Total RNA isolated by Trizol reagent (Invitrogen, USA)
were reverse transcribed to total cDNA with oligo dT. Quantitative
TaqMan real-time polymerase chain reaction (RT-PCR) was per-
formed for cyclin-dependent kinase inhibitor 1A (CDKN1A, p21)
according to the Taqman manufacturer’s instructions (Applied
Biosystems, USA). The housekeeping gene GAPDH was used as a
control. All primers were purchased from Applied Biosystems
(USA). The relative gene expression of p21 was calculated by nor-
malization to the expression level in phase-bright cells which was
considered as one.
Immunophenotype analysis by flow activated cell sorting
After harvesting, each cell fraction was labeled with CD34-allophy-
cocyanin, CD38-fluorescein isothiocyanate and CD45-PE (1:50;
Miltenyi Biotec, Germany) at 4°C for 45 min. Appropriate murine
antibodies served as a negative isotype control. After staining the cells
were acquired using a FACScalibur (BD, Germany) and analyzed by
CellQuest software (BD, Germany). Hematopoietic cells were gated
according to their forward and side scatter properties and CD45
expression. 
Cell generation tracking with carboxyfluorescein 
succinimidyl ester staining
Generations of HSC were identified using a CellTraceTM CFSE Cell
Proliferation Kit (Invitrogen, UK). Briefly, CD34+ HSC were labeled by
carboxyfluorescein succinimidyl ester (CFSE) according to the manu-
facturer’s instructions and placed in co-culture with MSC as described
above. At fixed time points, the cells from the various compartments
were collected and analyzed using FACS. The number of cell divisions
was quantified according to CFSE signal intensity using CellQuest
software. As a control CD34+ HSC were labeled with CFSE and treat-
ed with 50 μg/mL mitomycin (Santa Cruz) to arrest the cell popula-
tion at generation 0. The CD34 expression pattern throughout subse-
quent cell generations was evaluated by CD34-APC and CFSE double-
staining.
Colony-forming cell assay
The colony-forming assay was performed as described previously.24
Briefly, 1×103 cells from phase-bright and phase-dim fractions at day 5
were cultured for 14 days in complete methylcellulose medium with
recombinant cytokines (MethoCult GF+ H4435; Stem Cell
Technology, Vancouver, BC, Canada). Colony-forming units in culture
(CFU-C) were subsequently scored with an inverted microscope.
Experiments were performed in triplicate. Colonies were defined as
clusters consisting of 40 or more cells.
Inhibition of hematopoietic stem cell migration under
mesenchymal stromal cells by blocking integrin β1 
and CXCR4
HSC were cultured in suspension without a MSC layer for 2 days.
These primed HSC started to migrate under the MSC layer within 5
h. In addition, the primed HSC were pre-incubated for 1 h in normal
culture medium supplemented with either 10 µg/mL integrin β1 anti-
body (BD, Germany)28 or 500 ng/mL AMD3100 (a non-peptide antag-
onist of CXCR4; Sigma, USA)24 or both 500 ng/mL AMD3100 and 10
μg/mL integrin β1 antibody. After blocking, cells (1×105/mL) were
plated on the MSC layer for 5 h. Finally HSC from distinct localiza-
tions were counted using trypan blue, as mentioned before. P-selectin
antibody (10 μg/mL; BD, Germany) was used as a control.
Statistical analysis
All data were derived from at least three independent experiments.
Data are represented as the mean ± standard error of the mean (SEM)
and analyzed with the paired Student’s test. Observed differences
were regarded as statistically significant if the calculated two-sided P
value was below 0.05. 
Results
Identification of hematopoietic stem cell localization
To localize HSC co-cultured with MSC, we performed
scanning electron microscopy. Interestingly, two distinct
fractions of cells were observed (Figure 1A, B). HSC were
located either on the surface of the MSC layer or beneath
(Figure 1A). HSC were also detected migrating underneath
the MSC (Figure 1A, B). The time-lapse video microscopy
analysis depicted the movement of individual HSC migrat-
ing above or below the MSC layer (Figure 1C). By phase
contrast microscopy, the HSC population underneath the
MSC layer appeared as phase-dim cells whereas the HSC
located above appeared as phase-bright cells (Figure 1D).
The hematopoietic origin of these two cell fractions was
confirmed by immunolabeling for CD45 (Figure 1E).
Indeed, three optical confocal x-y–sections showed that
both phase-bright and phase-dim cells were positive for
D. Jing et al.
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CD45 (Figure 1F, H, respectively) whereas MSC were not
(Figure 1G). Upon gently washing (for technical details see
the Design and Methods section), the only remaining cells
were those underneath the MSC layer, i.e the phase-dim
cells (Figure 1I, J).
The mesenchymal stromal cell surface 
is the predominant site of hematopoietic stem 
cell proliferation
To determine the influence of cellular localization on
HSC expansion, we counted cells in their separated envi-
ronments. Until day 5 of co-culture, the numbers of non-
adherent and phase-bright cells increased similarly and
much faster than that of the phase-dim cells (Figure 2A).
After day 5 the number of non-adherent cells increased fur-
ther, while the number of phase-bright cells and phase-dim
cells remained constant (Figure 2A). Interestingly although
the cell count was highest for non-adherent cells, these
cells were not in the G2/M phase as demonstrated by pro-
pidium iodide staining. In fact, as shown in Figure 2 B and
C, the proportion of cells in the G2/M phase of the cell
cycle was higher for phase-bright cells than for either non-
adherent cells or phase-dim cells throughout the whole
week of co-culture: for example, on day 3: phase-bright
cells 11.9±2.7% versus non-adherent cells 0±0% (P<0.001)
and phase-dim cells 3.6 ± 2.4% (P<0.001) and on day 7:
phase-bright cells 13.9±1.0% versus non-adherent cells
1.3±1.2% (P<0.001) and phase-dim cells 2.7±2.0%
(P<0.001). This is consistent with the expression of p21
which is an essential regulator for the quiescence of HSC.29
p21 expression was significantly diminished in phase-
bright cells at day 5 (Figure 2D). These data indicate that,
in vitro, the MSC surface is enriched in proliferating proge-
ny and that phase-bright cells may detach from the MSC
surface on reaching a non-adherent status.
Hematopoietic stem and progenitor cells beneath 
the mesenchymal stromal cell layer remain immature
To investigate the impact of the localization on HSC dif-
ferentiation, HSC phenotypes were determined by FACS
analysis. CD34 is a classical HSC marker,30 and
CD34+CD38– cells are usually considered as a more primi-
tive HSC population.31 After apheresis we performed
MACS purification of CD34+ cells. We found that both
HSC in co-culture 
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Figure 1. Distinct compartmentalization of HSC cultured
on MSC. (A, B) Scanning electron microscopy analysis
revealed that HSC are either above the MSC layer (black
asterisks) or beneath (white arrow). HSC migrating
underneath the MSC layer were also observed (outlined
white asterisks). (C) Individual frames taken from a time-
lapse video depict an individual HSC moving above
(black arrow) and below (white arrow) the MSC layer for
a period of 54 min. M indicates MSC. (D) Phase-contrast
microscopy analysis shows that HSC located above or
beneath the MSC layer appeared as phase-bright and -
dim cells, respectively. (E) Confocal laser scanning
microscopy after immunolabeling for CD45. (F) Phase-
bright cells on the surface of the MSC layer. (G) MSC
layer. (H) Phase-dim cells beneath the MSC layer. (I)
Phase contrast microscopy of the cells beneath the MSC
layer (phase-dim cells), after removal of the phase-bright
cells. (J) A cross-section is shown using immunofluores-
cence imaging (actin, green; nucleus, blue; CD45, red).
Scale bar: 20 μm.
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CD34+ and CD34+CD38– cells were enriched in the phase-
dim fraction in comparison to in the phase-bright cells and
the non-adherent cells (Figure 3). At day 2, almost 100% of
phase-dim cells were CD34+CD38–, while the percentage
of CD34+CD38– cells within the non-adherent and phase-
bright fractions was below 75%. Over the following days,
the proportion of CD34+ and CD34+CD38– cells in the
phase-dim fraction decreased as well, but the drop was sig-
nificantly delayed in comparison to that in the other cell
D. Jing et al.
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Figure 2. Cell proliferation and cell cycle status. (A) Proliferation
kinetics of the three cell fractions (N=4). (B) Representative propid-
ium iodide (PI) staining of cells from the three distinct compart-
ments at day 3 and 7. (C) Dynamics of the three cell fractions in
G2/M phase during 1 week of co-culture (N=3). (D) Relative expres-
sion of p21 in the three compartments at day 5 (N=3, *P<0.05). The
data were normalized to the p21 expression in phase-bright cells,
which was arbitrarily set at one. 
Figure 3. Immunophenotype of the cells in the three compartments.
(A) Representative FACS analysis of the three cell fractions from day
2 to 7. The CD38+ cell fraction at day 4 is shown within the circle.
(B) Proportion of CD34+CD38– cells in the three cell fractions during
1 week of co-culture (N=7).
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fractions. As shown in Figure 3A, CD38 was more highly
expressed in non-adherent cells and phase-bright cells than
in phase-dim cells at day 4. In addition, we found a higher
concentration of clonogenic CFU-C within phase-dim cells
than within non-adherent cells or phase-bright cells
(phase-dim cells 150±20 colonies versus non-adherent cells
119±11 colonies (N = 6, P=0.07) and phase-bright cells
125±20 colonies (N = 6, P<0.05). 
Cell divisions in distinct localizations
To determine the impact of localization on cell division,
HSC generations were tracked by CFSE staining.
Generation 0 was represented by the control, which was
treated with mitomycin. The results of two representa-
tive experiments are shown in Figure 4A. At day 2,
approximately 50% of phase-dim cells had not divided
(generation 0), while less than 20% of the other two cell
fractions were generation 0 cells. Over the following
days, the proportion of cells that had undergone few divi-
sions was higher among phase-dim cells than among the
other two cell fractions. Comparing the distribution of
cell generations in the three compartments at days 2, 3
HSC in co-culture 
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Figure 4. Tracking cell division in the three distinct compartments using CFSE staining. (A) Representative FACS analysis of CFSE staining
at days 2 and 3. Cell generations were identified according to the control cells which were treated with mitomycin at day 0 (gray peak). (B)
Distributions of cell generations of the three cell fractions at days 2, 3 and 4 (N=3). The pattern of CD34 expression in the different cell
generations was studied. (C) Representative FACS analysis of CD34 and CFSE double staining at days 3 and 5. The dots in the gray region
represent cells positive for CD34, the dots in the white region represent cells negative for CD34. Cell generations were identified according
to the control cells which were treated with mitomycin at day 0. (D) CD34+ expression over eight cell generations within the three cell frac-
tions (N = 8).
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and 4, the data indicate the down-regulating impact of
the compartment beneath the MSC on cell division
(Figure 4B).
Immunophenotypes after each cell division
In order to determine the retention of the progenitor
phenotype after each cell division, CFSE and CD34 dou-
ble staining was performed in the three separated groups.
After the first two cell divisions (in HSC, generations 0, 1
and 2), almost all cells from all three localizations were
CD34+ (Figure 4C). However, in generations 3 and 4 only
the phase-dim population retained a high percentage of
CD34-expressing cells, which indicates their delayed dif-
ferentiation compared to the other two cell fractions. As
shown in Figure 4D, in the following cell divisions there
were always more phase-dim cells that retained CD34
expression compared to the same HSC generation of the
other two cell fractions. Taken together, the outcome of
HSC division differed according to the localization of the
cells, suggesting that the more slowly proliferating HSC
grown beneath MSC retain their stem cell characteristics
during cell division.
Immature hematopoietic stem cells migrate beneath
the mesenchymal stromal cell layer
We then investigated whether more immature cells pre-
fer the compartment beneath the MSC layer, migrating
directly to this area in vitro. As already mentioned we
detected phase-dim cells in newly established co-cultures
only after day 2. However when purified HSC were cul-
tured without MSC in a cytokine-supplemented medium
for 4 days and then seeded on a MSC layer in a second
culture, as described in the Design and Methods section,
we saw up to 6% phase-dim cells already after 5 h of co-
culture, indicating that primed HSC had an increased
capacity for migration beneath the MSC layer. As shown
in Figure 5A, HSC, of which 54.67±2.55% had a
CD34+CD38– phenotype, were plated on the MSC layer.
After 5 h the CD34+CD38– cells (78.23±7.65%) were
enriched in the phase-dim fraction, suggesting that more
immature HSC preferentially home beneath the MSC
layer.
CXCR4 and integrins influence phase-dim
cell formation
Recently we demonstrated that CXCR4 is up-regulated
in the adherent-cell fraction in comparison to the non-
adherent cell fraction.24 Other adhesion molecules, such
as integrins, are also important for homing and migra-
tion.28,32,33 The assay described above allowed us to inves-
tigate the impact of surface molecules on the primary
attachment and migration of HSC underneath the MSC
layer. First we blocked integrin β1. As shown in Figure 5B,
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Figure 5. (A) Enrichment of CD34+CD38–cells in the phase-dim frac-
tion. Cells containing around 50% CD34+CD38– cells were plated on
the MSC layer. After 5 h the proportion of CD34+CD38– cells among
the phase-dim fraction was enriched up to 80% (N=4, *P<0.01). (B)
Blocking experiments for P-selectin, integrin β1 and CXCR4. By block-
ing integrin β1 or CXCR4 or both, percentages of phase-bright or
phase-dim cells were down-regulated (N = 4, *P<0.01 (relative to
control); #P<0.05 (relative to individual blocking for integrin β1 or
CXCR4). 
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Figure 6. Graphic of the in vitro HSC/MSC co-culture system. (A)
Migration towards and retention of HSC to MSC is mediated by
SDF1/CXCR4 and adhesion molecules such as integrins. (B) The
MSC layer serves in vitro as a boundary between two distinct com-
partments, i.e. the MSC surface mediating cell proliferation and a
niche-like compartment beneath the layer. Here beneath the layer,
phase-dim (PD) cells show a delayed cell-cycle activity and a more
immature phenotype. In contrast, phase-bright (PB) HSC on the MSC
surface revealed significantly more proliferation activity. We assume
that cells from the MSC surface are released into the supernatant,
the third microenvironment (non-adherent cells, NA) in the co-culture
system. The graphic illustrates the dynamic interplay of HSC in the
three compartments.
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this had the effect of reducing phase-bright cells from
69.89±4.08% to 40.56±12.45% (P<0.01) and phase-dim
cells from 7.18±1.50% to 3.38%±1.19% (P<0.01), indi-
cating that at least integrin β1 takes part in the process of
HSC adhesion on the MSC surface and migration beneath
the MSC layer. Next we blocked CXCR4 by adding
AMD3100 (Figure 5B). Although the count of phase-
bright cells was not reduced (69.89±4.08% versus
75.33±8.42%), phase-dim cells were diminished from
7.18±1.50% to 3.19±0.77% (P<0.01), indicating that in
our assay CXCR4 plays a role in HSC migration beneath
the MSC layer. Finally by blocking both CXCR4 and inte-
grin β1, the count of phase-dim cells was reduced to
1.97±0.18%, which is a further reduction compared to
that produced by individual blocking of integrin β1 or
CXCR4 (3.38±1.19% and 3.19±0.77%, respectively),
indicating that both integrins and CXCR4 are involved in
the migration of HSC beneath the MSC feeder layer. Our
data also confirm that CXCR4 has no impact on adhe-
siveness, as we have already recently described.24
Blocking P-selectin as a control did not cause significant
decreases of phase-bright or phase-dim cells.
Discussion
Many studies have demonstrated that HSC can be
expanded in cytokine-driven culture. However, this kind
of expansion is accompanied by concomitant differentia-
tion and gradual loss of ‘stemness’. In recent years, it has
been shown that stromal feeder layers can be used to sup-
port HSC expansion. It has become evident that the inter-
action between HSC and MSC is an important issue for
keeping HSC quiescent both in vivo and in vitro.11 We and
others have shown that cell-to-cell contact in vitro has a
significant impact on the functional, phenotypic, and
clonogenic parameters of HSC. We have also demonstrat-
ed that direct contact with MSC affects the migratory
behavior and gene expression profile of CD133+ HSC dur-
ing ex vivo expansion.24
In the present study, we investigated the distribution of
HSC in the co-culture assay in more detail. We observed
that three different sites in the co-culture system repre-
sent distinct microenvironments for HSC, with a signifi-
cant impact on their fate in vitro. By performing phase-
contrast, confocal and electron microscopy, we separated
HSC that were non-adherent, cells adherent to the sur-
face of the MSC layer, and cells that had migrated
beneath the feeder layer. A confluent MSC layer may
serve as a boundary between two distinct compartments.
These spatial constraints influence the proliferation and
differentiation of HSC. One remarkable difference is the
cell cycle status of cultured HSC. It is known that imme-
diately after HSC have been isolated from peripheral
blood, they usually are in G0/G1.34 Their status, howev-
er, changes if the cells are plated out in expansion assays
with stimulating factors.13 In our study phase-bright cells
significantly and consistently showed an increase of
G2/M cells (over 10%) throughout the whole culture
period. In contrast, among the non-adherent and phase-
dim fractions, there were almost no cells in the G2/M
phase. Thus, G2/M phase cells were mainly on the sur-
face and not in a non-adherent fraction. However, the
number of non-adherent cells increased continuously,
suggesting that the adherent fraction supplies the non-
adherent fraction with detaching cells. We have evidence
that the cell-to-cell contact on the surface of the MSC
layer promotes the cell cycle, although the mechanism
has not yet been clarified in detail.
Interestingly we found that in our co-culture system the
translocation between HSC on the surface and those
beneath the MSC layer was between two distinct com-
partments. Performing serial studies we found that phase-
dim cells retained a more immature phenotype compared
to that of the HSC on the surface of the MSC layer and
had a significantly delayed rate of cell division in compar-
ison to the other two cell fractions. We, therefore, specu-
late that the MSC boundary layer has a significant effect
on HSC fate. Admittedly, HSC are highly motile and able
to move between the compartments. Our daily measure-
ments still represent snap-shots taken at defined time-
points, which may not represent the whole complex
dynamics of the process. 
It is still not clear whether the environment beneath the
MSC layer actively keeps HSC in an immature state or
whether it creates a ‘niche’ atmosphere that specifically
attracts HSC. We speculate that both mechanisms are
involved. We were at least able to demonstrate that
CD34+CD38– HSC preferentially migrate through the
MSC layer. 
The interaction between HSC and MSC, via soluble
factors (SDF1/CXCR4) or adhesion molecules (integrins),
also has an impact on HSC migration between the two
microenvironments. Phase-dim cell formation was
reduced by blocking integrins and CXCR4. This effect
was further enhanced by combined blockade, indicating
that β1-integrins and the SDF1/CXCR4 axis play syner-
gistic roles in phase-dim cell formation. Interestingly the
count of phase-bright cells was not reduced by
AMD3100, indicating that CXCR4 is not relevant in
adhesiveness, confirming our recently published data.24
In summary, we were able to distinguish three different
compartments in our co-culture system: (i) the super-
natant, i.e. the milieu in which HSC grow without direct
contact with MSC; (ii) the surface of MSC; and (iii) the
environment beneath the MSC layer. All three locations
are dynamically linked with each other, and are charac-
terized by special features. Specifically, the niche-like
microenvironment (i.e. beneath MSC) probably recruits
and retains HSC with more primitive properties whereas
the MSC surface favors the active expansion of HSC. 
Interestingly, in vivo there is a similar but certainly even
more complex system of niches. It has been reported that
quiescent HSC are preferentially located in osteoblastic
niches, while more actively cycling and self-renewing
HSC are kept in the perivascular niche.11,35 The three-com-
partment co-culture system probably mimics the cooper-
ation of stem cell niches in vivo.
The model of the HSC in vitro niche is illustrated in
Figure 6, showing the MSC surface as the major site of
HSC proliferation and the microenvironment beneath the
MSC layer as the storage site of more primitive cells, all
affected by an orchestra of various soluble and non-solu-
ble signals. Further investigations are needed to study the
complex mechanism of HSC expansion in vitro, including
investigation of the repopulating potential of the different
cell fractions by performing in-vivo repopulation experi-
ments.
HSC in co-culture 
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